Ratings by RBC Capital (Daniel Busb)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/17/2021 Pfizer PFE Maintain Sector Perform
(N/A)
 
 
  Details
6/8/2021 Merck MRK Maintain Sector Perform
(N/A)
 
 
  Details
5/14/2021 Xeris Pharmaceuticals XERS Maintain Outperform
(N/A)
 
 
  Details
5/13/2021 Flexion Therapeutics FLXN Maintain Outperform
(N/A)
 
 
  Details
5/11/2021 Viatris VTRS Maintain Outperform
(N/A)
 
 
  Details
5/11/2021 Eagle Pharmaceuticals EGRX Maintain Outperform
(N/A)
 
 
  Details
5/10/2021 Endo International plc ENDP Maintain Sector Perform
(N/A)
 
 
  Details
5/6/2021 Optinose OPTN Maintain Outperform
(N/A)
 
 
  Details
5/5/2021 Pfizer PFE Maintain Sector Perform
(N/A)
 
 
  Details
5/5/2021 Jazz Pharmaceuticals JAZZ Maintain Outperform
(N/A)
 
 
  Details
5/5/2021 Agile Therapeutics AGRX Maintain Outperform
(N/A)
 
 
  Details
5/3/2021 Abbvie ABBV Maintain Outperform
(N/A)
 
 
  Details
4/30/2021 Merck MRK Maintain Sector Perform
(N/A)
 
 
  Details
4/7/2021 Xeris Pharmaceuticals XERS New Coverage Outperform
(N/A)
4.37
(4.32)
-1.14% Details
4/7/2021 Viatris VTRS New Coverage Outperform
(N/A)
14.05
(14.36)
2.21% Details
4/7/2021 Teva Pharma TEVA New Coverage Sector Perform
(N/A)
11.56
(10.42)
-9.86% Details
4/7/2021 Perrigo Co. PRGO New Coverage Sector Perform
(N/A)
40.39
(46.24)
14.48% Details
4/7/2021 Pfizer PFE New Coverage Sector Perform
(N/A)
36.28
(39.19)
8.02% Details
4/7/2021 Pacira Pharmaceuticals PCRX New Coverage Outperform
(N/A)
68.89
(61.61)
-10.57% Details
4/7/2021 Osmotica OSMT New Coverage Outperform
(N/A)
3.45
(2.84)
-17.68% Details
4/7/2021 Optinose OPTN New Coverage Outperform
(N/A)
3.57
(3.30)
-7.56% Details
4/7/2021 Merck MRK New Coverage Sector Perform
(N/A)
77.00
(76.36)
-0.83% Details
4/7/2021 Jazz Pharmaceuticals JAZZ New Coverage Outperform
(N/A)
164.71
(178.80)
8.55% Details
4/7/2021 Flexion Therapeutics FLXN New Coverage Outperform
(N/A)
8.82
(9.22)
4.54% Details
4/7/2021 Endo International plc ENDP New Coverage Sector Perform
(N/A)
7.19
(4.89)
-31.99% Details
4/7/2021 Eagle Pharmaceuticals EGRX New Coverage Outperform
(N/A)
41.28
(43.10)
4.41% Details
4/7/2021 Aquestive Therapeutics AQST New Coverage Outperform
(N/A)
5.21
(4.32)
-17.08% Details
4/7/2021 Amneal Pharmaceuticals AMRX New Coverage Sector Perform
(N/A)
0.08
(117.40)
146650% Details
4/7/2021 Agile Therapeutics AGRX New Coverage Outperform
(N/A)
2.06
(1.40)
-32.04% Details
4/7/2021 Abbvie ABBV New Coverage Outperform
(N/A)
106.14
(114.74)
8.1% Details